<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35039323</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>81</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of the rheumatic diseases</Title>
          <ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cutaneous signs and mechanisms of inflammasomopathies.</ArticleTitle>
        <Pagination>
          <StartPage>454</StartPage>
          <EndPage>465</EndPage>
          <MedlinePgn>454-465</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2021-220977</ELocationID>
        <Abstract>
          <AbstractText>The emerging group of autoinflammatory diseases (AIDs) is caused by a dysregulation of the innate immune system while lacking the typical footprint of adaptive immunity. A prominent subgroup of AIDs are inflammasomopathies, which are characterised by periodic flares of cutaneous signs as well as systemic organ involvement and fever. The range of possible skin lesions is vast, ranging from urticarial, erysipelas-like and pustular rashes to erythematous patches, violaceous plaques and eventual necrosis and ulceration. This review provides a structured overview of the pathogenesis and the clinical picture with a focus on dermatological aspects of inflammasomopathies. Current treatment options for these conditions are also discussed.</AbstractText>
          <CopyrightInformation>© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Borst</LastName>
            <ForeName>Carina</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-3451-7820</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Medical University of Vienna, Wien, Austria carina.borst@meduniwien.ac.at doerte.symmank@meduniwien.ac.at.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Symmank</LastName>
            <ForeName>Dörte</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0002-3992-6447</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Medical University of Vienna, Wien, Austria carina.borst@meduniwien.ac.at doerte.symmank@meduniwien.ac.at.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drach</LastName>
            <ForeName>Mathias</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Medical University of Vienna, Wien, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weninger</LastName>
            <ForeName>Wolfgang</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0003-3133-8699</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Medical University of Vienna, Wien, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ann Rheum Dis</MedlineTA>
        <NlmUniqueID>0372355</NlmUniqueID>
        <ISSNLinking>0003-4967</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000163" MajorTopicYN="Y">Acquired Immunodeficiency Syndrome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010505" MajorTopicYN="Y">Familial Mediterranean Fever</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056660" MajorTopicYN="Y">Hereditary Autoinflammatory Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012871" MajorTopicYN="Y">Skin Diseases</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">cryopyrin-associated periodic syndromes</Keyword>
        <Keyword MajorTopicYN="Y">cytokines</Keyword>
        <Keyword MajorTopicYN="Y">familial Mediterranean fever</Keyword>
        <Keyword MajorTopicYN="Y">immune system diseases</Keyword>
        <Keyword MajorTopicYN="Y">inflammation</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>18</Day>
          <Hour>5</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35039323</ArticleId>
        <ArticleId IdType="doi">10.1136/annrheumdis-2021-220977</ArticleId>
        <ArticleId IdType="pii">annrheumdis-2021-220977</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
